Gachet Christian
Institut National de la Santé et de la Recherche Médicale, Unité 311, Etablissement Français du Sang-Alsace, Strasbourg 67065, France.
Annu Rev Pharmacol Toxicol. 2006;46:277-300. doi: 10.1146/annurev.pharmtox.46.120604.141207.
The main role of blood platelets is to ensure primary hemostasis, which is the maintenance of vessel integrity and cessation of bleeding upon injury. While playing a major part in acute arterial thrombosis, platelets are also involved in inflammation, atherosclerosis, and angiogenesis. ADP and ATP play a crucial role in platelet activation, and their receptors are potential targets for antithrombotic drugs. The ATP-gated cation channel P2X(1) and the two G protein-coupled ADP receptors, P2Y(1) and P2Y(12), selectively contribute to platelet aggregation and formation of a thrombus. Owing to its central role in the growth and stabilization of a thrombus, the P2Y(12) receptor is an established target of antithrombotic drugs such as clopidogrel. Studies in P2Y(1) and P2X(1) knockout mice and selective P2Y(1) and P2X(1) antagonists have shown that these receptors are also attractive targets for new antithrombotic compounds. The potential role of platelet P(2) receptors in the involvement of platelets in inflammatory processes is also discussed.
血小板的主要作用是确保初级止血,即维持血管完整性并在受伤时停止出血。血小板在急性动脉血栓形成中起主要作用,同时也参与炎症、动脉粥样硬化和血管生成过程。二磷酸腺苷(ADP)和三磷酸腺苷(ATP)在血小板活化中起关键作用,它们的受体是抗血栓药物的潜在靶点。ATP门控阳离子通道P2X(1)以及两种G蛋白偶联的ADP受体P2Y(1)和P2Y(12),分别对血小板聚集和血栓形成有选择性作用。由于P2Y(12)受体在血栓生长和稳定中起核心作用,它是氯吡格雷等抗血栓药物已确定的靶点。对P2Y(1)和P2X(1)基因敲除小鼠以及选择性P2Y(1)和P2X(1)拮抗剂的研究表明,这些受体也是新型抗血栓化合物的有吸引力的靶点。本文还讨论了血小板P(2)受体在血小板参与炎症过程中的潜在作用。